Chan Heng Fai Ambrose 4
4 · IMPACT BIOMEDICAL INC. · Filed Apr 7, 2025
Insider Transaction Report
Form 4
Chan Heng Fai Ambrose
Director10% Owner
Transactions
- Sale
Common stock
2025-04-03$0.49/sh−351,555$174,020→ 0 total(indirect: See footnote)
Footnotes (2)
- [F1]On April 3, 2025, Alset International Limited sold 351,555 shares of the Issuer's common stock at a weighted average sale price of $0.495. This transaction was executed in multiple trades at prices ranging from $0.46 to $0.57. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc.